Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Time-Resolved Dynamic Optical Coherence Tomography for Retinal Blood Flow Analysis.
Valmaggia P, Cattin PC, Sandkühler R, Inglin N, Otto TP, Aumann S, Teussink MM, Spaide RF, Scholl HPN, Maloca PM. Valmaggia P, et al. Among authors: aumann s. Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):9. doi: 10.1167/iovs.65.6.9. Invest Ophthalmol Vis Sci. 2024. PMID: 38837167 Free PMC article.
Lateral Resolution of a Commercial Optical Coherence Tomography Instrument.
Spaide RF, Otto T, Caujolle S, Kübler J, Aumann S, Fischer J, Reisman C, Spahr H, Lessmann A. Spaide RF, et al. Among authors: aumann s. Transl Vis Sci Technol. 2022 Jan 3;11(1):28. doi: 10.1167/tvst.11.1.28. Transl Vis Sci Technol. 2022. PMID: 35044444 Free PMC article.
Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia.
Kugler E, Cohen I, Amitai I, Ram R, Frisch A, Nachmias B, Canaani J, Moshe Y, Krayem B, Aumann S, Henig I, Vainstein V, Shargian L, Ganzel C, Yeshurun M, Levi I, Raanani P, Akria L, Ofran Y, Shimony S, Wolach O. Kugler E, et al. Among authors: aumann s. Br J Haematol. 2024 Sep;205(3):932-941. doi: 10.1111/bjh.19548. Epub 2024 May 23. Br J Haematol. 2024. PMID: 38782575
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study.
Berger T, Shochat T, Aumann S, Nachmias B, Goldschmidt N, Horesh N, Harel R, Aviv A, Shmerts E, Abadi U, Shimony S, Raanani P, Gafter-Gvili A, Gurion R. Berger T, et al. Among authors: aumann s. Ann Hematol. 2023 Aug;102(8):2127-2136. doi: 10.1007/s00277-023-05306-2. Epub 2023 Jun 19. Ann Hematol. 2023. PMID: 37335322
35 results